Compare Stocks

Anglo-Bomarc Mines Ltd. engages in the exploration, development, and evaluation of mineral properties primarily in Canada. It holds interests in the Dynasty Gold and Jade projects totaling 845 hectares located in the Cassiar region in British Columbia; and the ANB Yukon Gold and Diamond projects totaling approximately 70 acres located in Mount Nansen of the northern territory of Yukon. The company also holds interests in the Boston Bar project that consists of nine claims covering an area of approximately 187 hectares located in the Boston Bar area of southwestern British Columbia; and the Quesnel Property, which consists of two claims covering an area of approximately 59 hectares. Anglo-Bomarc Mines Ltd. was founded in 1967 and is based in Vancouver, Canada.

Batero Gold Corp., together with its subsidiaries, engages in the exploration and development of mineral properties in Colombia. The company explores for gold, copper, silver, antimony, hydrargyrum, autonomous system, lead, zinc, and molybdenum deposits. It owns a 100% interest in the Batero-Quinchia project, which consists of 1,407 hectares tenement and one application for a concession contract of 155 hectares located in the municipality of Quinchia, Department of Risaralda, Colombia. The company was formerly known as Angus Resources Inc. and changed its name to Batero Gold Corp. in July 2010. Batero Gold Corp. was incorporated in 2008 and is headquartered in Toronto, Canada.

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.

Mexican Gold Mining Corp., a mineral exploration company, engages in the acquisition, exploration, and evaluation of resource properties in Mexico. The company primarily explores for gold and copper deposits. It holds a 100% interest in the Las Minas project that consists of six mineral concessions located in the Las Minas district in the state of Veracruz, Mexico. Mexican Gold Mining Corp. was incorporated in 2006 and is based in Vancouver, Canada.